Evaluation of Hybrid Arc and Volumetric-Modulated Arc Therapy Treatment Plans for Fractionated Stereotactic Intracranial Radiotherapy von Li, Jun, To, David, Gunn, Vickie, Shi, Wenyin, Yu, Yan, Liu, Haisong

Volltext

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma von Kim, Hyun, Potrebko, Peter, Rivera, Amanda, Liu, Haisong, Eldredge-Hindy, Harriet B, Gunn, Vickie, Werner-Wasik, Maria, Andrews, David W, Evans, James J, Farrell, Christopher J, Judy, Kevin, Shi, Wenyin

Volltext

Tumor Volume Threshold for Achieving Improved Conformity Index in VMAT and Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannoma von Kim, Hyun, Potrebko, Peter, Rivera, Amanda, Liu, Haisong, Eldredge-Hindy, Harriet B., Gunn, Vickie, Werner-Wasik, Maria, Andrews, David W., Evans, James J., Farrell, Christopher J., Judy, Kevin, Shi, Wenyin

Volltext

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor von Hallin, Jill, Bowcut, Vickie, Calinisan, Andrew, Briere, David M., Hargis, Lauren, Engstrom, Lars D., Laguer, Jade, Medwid, James, Vanderpool, Darin, Lifset, Ella, Trinh, David, Hoffman, Natalie, Wang, Xiaolun, David Lawson, J., Gunn, Robin J., Smith, Christopher R., Thomas, Nicole C., Martinson, Matthew, Bergstrom, Alex, Sullivan, Francis, Bouhana, Karyn, Winski, Shannon, He, Leo, Fernandez-Banet, Julio, Pavlicek, Adam, Haling, Jacob R., Rahbaek, Lisa, Marx, Matthew A., Olson, Peter, Christensen, James G.

Volltext

Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein–Protein Interaction von Ketcham, John M., Haling, Jacob, Khare, Shilpi, Bowcut, Vickie, Briere, David M., Burns, Aaron C., Gunn, Robin J., Ivetac, Anthony, Kuehler, Jon, Kulyk, Svitlana, Laguer, Jade, Lawson, J. David, Moya, Krystal, Nguyen, Natalie, Rahbaek, Lisa, Saechao, Barbara, Smith, Christopher R., Sudhakar, Niranjan, Thomas, Nicole C., Vegar, Laura, Vanderpool, Darin, Wang, Xiaolun, Yan, Larry, Olson, Peter, Christensen, James G., Marx, Matthew A.

Volltext

Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery von Mehta, Rajendra H, Leimberger, Jeffrey D, van Diepen, Sean, Meza, James, Wang, Alice, Jankowich, Rachael, Harrison, Robert W, Hay, Douglas, Fremes, Stephen, Duncan, Andra, Soltesz, Edward G, Luber, John, Park, Soon, Argenziano, Michael, Murphy, Edward, Marcel, Randy, Kalavrouziotis, Dimitri, Nagpal, Dave, Bozinovski, John, Toller, Wolfgang, Heringlake, Matthias, Goodman, Shaun G, Levy, Jerrold H, Harrington, Robert A, Anstrom, Kevin J, Alexander, John H

Volltext

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor von Wang, Xiaolun, Allen, Shelley, Blake, James F, Bowcut, Vickie, Briere, David M, Calinisan, Andrew, Dahlke, Joshua R, Fell, Jay B, Fischer, John P, Gunn, Robin J, Hallin, Jill, Laguer, Jade, Lawson, J. David, Medwid, James, Newhouse, Brad, Nguyen, Phong, O’Leary, Jacob M, Olson, Peter, Pajk, Spencer, Rahbaek, Lisa, Rodriguez, Mareli, Smith, Christopher R, Tang, Tony P, Thomas, Nicole C, Vanderpool, Darin, Vigers, Guy P, Christensen, James G, Marx, Matthew A

Volltext

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor von Wang, Xiaolun, Allen, Shelley, Blake, James F, Bowcut, Vickie, Briere, David M, Calinisan, Andrew, Dahlke, Joshua R, Fell, Jay B, Fischer, John P, Gunn, Robin J, Hallin, Jill, Laguer, Jade, Lawson, J David, Medwid, James, Newhouse, Brad, Nguyen, Phong, O'Leary, Jacob M, Olson, Peter, Pajk, Spencer, Rahbaek, Lisa, Rodriguez, Mareli, Smith, Christopher R, Tang, Tony P, Thomas, Nicole C, Vanderpool, Darin, Vigers, Guy P, Christensen, James G, Marx, Matthew A

Volltext

Abstract ND02: MRTX0902: A SOS1 inhibitor for therapeutic intervention of KRAS-driven cancers von Ketcham, John M., Khare, Shilpi, Sudhakar, Niranjan, Briere, David M., Yan, Larry, Laguer, Jade, Vegar, Laura, Vanderpool, Darin, Hallin, Jill, Hargis, Lauren, Bowcut, Vickie, Lawson, David, Gunn, Robin J., Ivetac, Anthony, Thomas, Nicole C., Saechao, Barbara, Nguyen, Natalie, Clarine, Jeffrey, Rahbaek, Lisa, Smith, Christopher R., Burns, Aaron C., Marx, Matthew A., Christensen, James G., Olson, Peter, Haling, Jacob R.

Volltext

Abstract 1131: Pharmacogenomic insight into targetable vulnerabilities and modifiers of response to MRTX1133 in KRASG12D-mutant models von Bowcut, Vickie, Calinisan, Andrew, Briere, David M., Hargis, Lauren, Engstrom, Lars D., Laguer, Jade, Vanderpool, Darin, Wang, Xiaolun, Lawson, J David, Thomas, Nicole, Gunn, Robin, Smith, Christopher R., Fernandez-Banet, Julio, He, Leo, Pavlicek, Adam, Rahbaek, Lisa, Marx, Matthew A., Olson, Peter, Christensen, James G., Hallin, Jill

Volltext

Anti-tumor efficacy of a potent and selective non-covalent KRAS G12D inhibitor von Hallin, Jill, Bowcut, Vickie, Calinisan, Andrew, Briere, David M, Hargis, Lauren, Engstrom, Lars D, Laguer, Jade, Medwid, James, Vanderpool, Darin, Lifset, Ella, Trinh, David, Hoffman, Natalie, Wang, Xiaolun, David Lawson, J, Gunn, Robin J, Smith, Christopher R, Thomas, Nicole C, Martinson, Matthew, Bergstrom, Alex, Sullivan, Francis, Bouhana, Karyn, Winski, Shannon, He, Leo, Fernandez-Banet, Julio, Pavlicek, Adam, Haling, Jacob R, Rahbaek, Lisa, Marx, Matthew A, Olson, Peter, Christensen, James G

Volltext